10x Genomics (TXG) Cash from Operations Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.29 Bn | 27.22 Bn | 1.98 Bn | 16.00% |
| 2 | Veeva Systems | 26.21 Bn | 19.65 Bn | 622.47 Mn | 53.64% |
| 3 | BrightSpring Health Services | 11.98 Bn | 11.10 Bn | 482.22 Mn | 21.01% |
| 4 | Healthequity | 7.59 Bn | 7.27 Bn | 228.15 Mn | 55.67% |
| 5 | Hinge Health | 4.34 Bn | 4.03 Bn | 154.23 Mn | 774.78% |
| 6 | Waystar Holding | 3.75 Bn | 3.59 Bn | 268.04 Mn | 32.16% |
| 7 | Doximity | 3.73 Bn | 2.98 Bn | 125.97 Mn | 11.20% |
| 8 | 10x Genomics | 3.04 Bn | 2.50 Bn | 106.18 Mn | -23.96% |
| 9 | Privia Health | 2.83 Bn | 2.46 Bn | 595.71 Mn | -105.58% |
| 10 | Omnicell | 2.01 Bn | 1.84 Bn | 140.36 Mn | 110.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.96% |
| Dec 31, 2025 | 704.28% |
| Sep 30, 2025 | 99.69% |
| Jun 30, 2025 | 136.23% |
| Mar 31, 2025 | 318.45% |
| Dec 31, 2024 | -126.20% |
| Sep 30, 2024 | 185.52% |
| Jun 30, 2024 | 165.04% |
| Mar 31, 2024 | -281.21% |
| Dec 31, 2023 | 87.70% |
| Sep 30, 2023 | -164.58% |
| Jun 30, 2023 | 32.05% |
| Mar 31, 2023 | 80.17% |
| Dec 31, 2022 | 136.40% |
| Sep 30, 2022 | 63.52% |
| Jun 30, 2022 | -643.69% |
| Mar 31, 2022 | -409.60% |
| Dec 31, 2021 | 104.46% |
| Sep 30, 2021 | 52.87% |
| Jun 30, 2021 | 110.57% |
| Mar 31, 2021 | -58.46% |
| Dec 31, 2020 | -2,042.91% |
| Sep 30, 2020 | -482.96% |
| Jun 30, 2020 | -822.95% |
| Mar 31, 2020 | -127.65% |
| Dec 31, 2019 | 113.14% |